Fate Therapeutics stockholders approve charter amendment to exculpate officers

FATE THERAPEUTICS INC

Certificate of Amendment to Amended and Restated Certificate of Incorporation approved by stockholders at Annual Meeting on June 7, 2024.
Amendment allows exculpation of certain officers, limiting personal liability for breaches of fiduciary duty.
Effective upon filing with Delaware Secretary of State on June 7, 2024.
Board recommended the amendment; stockholders voted to approve.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.